Alexandria For Pharmaceuticals & Chemical Industries Balance Sheet Health
Financial Health criteria checks 5/6
Alexandria For Pharmaceuticals & Chemical Industries has a total shareholder equity of EGP795.0M and total debt of EGP813.1K, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are EGP1.2B and EGP446.0M respectively. Alexandria For Pharmaceuticals & Chemical Industries's EBIT is EGP267.5M making its interest coverage ratio -19.8. It has cash and short-term investments of EGP150.0M.
Key information
0.1%
Debt to equity ratio
ج.م813.07k
Debt
| Interest coverage ratio | -19.8x |
| Cash | ج.م150.04m |
| Equity | ج.م794.98m |
| Total liabilities | ج.م446.04m |
| Total assets | ج.م1.24b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AXPH's short term assets (EGP858.9M) exceed its short term liabilities (EGP436.5M).
Long Term Liabilities: AXPH's short term assets (EGP858.9M) exceed its long term liabilities (EGP9.6M).
Debt to Equity History and Analysis
Debt Level: AXPH has more cash than its total debt.
Reducing Debt: AXPH's debt to equity ratio has increased from 0% to 0.1% over the past 5 years.
Debt Coverage: AXPH's debt is well covered by operating cash flow (23322%).
Interest Coverage: AXPH earns more interest than it pays, so coverage of interest payments is not a concern.